Literature DB >> 27163969

LC-MS/MS as a tool for TDM services: Where are we?

Maria Shipkova1, Dobrin Svinarov2.   

Abstract

Keywords:  Anticancer drugs; Antiepileptics; Antifungals; Antimicrobials; Antipsychotics; Antiviral drugs; Cardioactive drugs; Immunosuppresants; Method standardization; Therapeutic drug monitoring

Mesh：

Year:  2016        PMID： 27163969     DOI： 10.1016/j.clinbiochem.2016.05.001

Source DB:  PubMed          Journal:  Clin Biochem        ISSN： 0009-9120            Impact factor:   3.281


× No keyword cloud information.
  9 in total

1.  Direct and Precise Measurement of Bevacizumab Levels in Human Plasma Based on Controlled Methionine Oxidation and Multiple Reaction Monitoring.

Authors:  Vanessa P Gaspar; Sahar Ibrahim; Constance A Sobsey; Vincent R Richard; Alan Spatz; René P Zahedi; Christoph H Borchers
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-13

2.  Measurement of caffeine and its three primary metabolites in human plasma by HPLC-ESI-MS/MS and clinical application.

Authors:  Feng Chen; Zhe-Yi Hu; Robert B Parker; S Casey Laizure
Journal:  Biomed Chromatogr       Date:  2017-01-04       Impact factor: 1.902

3.  A semi-automated, isotope-dilution high-resolution mass spectrometry assay for therapeutic drug monitoring of antidepressants.

Authors:  Johanna M Lindner; Michael Vogeser; Katharina Sorg; Stefanie H Grimm
Journal:  Clin Mass Spectrom       Date:  2019-05-21

4.  Quantification and Determination of Stability of Tylvalosin in Pig Plasma by Ultra-High Liquid Chromatography with Ultraviolet Detection.

Authors:  Verónica Hernandis; Elisa Escudero; Juan Sebastián Galecio; Pedro Marín
Journal:  Animals (Basel)       Date:  2022-05-27       Impact factor: 3.231

Review 5.  Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs.

Authors:  Johanna Kuhlin; Marieke G G Sturkenboom; Samiksha Ghimire; Ioana Margineanu; Simone H J van den Elsen; Noviana Simbar; Onno W Akkerman; Erwin M Jongedijk; Remco A Koster; Judith Bruchfeld; Daan J Touw; Jan-Willem C Alffenaar
Journal:  Clin Mass Spectrom       Date:  2018-10-19

6.  Development of a methodology to make individual estimates of the precision of liquid chromatography-tandem mass spectrometry drug assay results for use in population pharmacokinetic modeling and the optimization of dosage regimens.

Authors:  Gellért Balázs Karvaly; Michael N Neely; Krisztián Kovács; István Vincze; Barna Vásárhelyi; Roger W Jelliffe
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

7.  Validation of a novel UPLC-HRMS method for human whole-blood cyclosporine and comparison with a CMIA immunoassay.

Authors:  Xiaoxue Wang; Wei Qin; Wenqian Chen; Huifang Liu; Dan Zhang; Xianglin Zhang; Pengmei Li
Journal:  Exp Ther Med       Date:  2021-01-07       Impact factor: 2.447

8.  Simultaneous LC-ESI-MS/MS Quantification of Levosimendan and Its Metabolites for Therapeutic Drug Monitoring of Cardiac Surgery Patients.

Authors:  Hannah Kipka; Roland Tomasi; Max Hübner; Uwe Liebchen; Christian Hagl; Klaus T Wanner; Hanna Mannell; Georg Höfner
Journal:  Pharmaceutics       Date:  2022-07-12       Impact factor: 6.525

9.  Comparison of LC-MS/MS and EMIT methods for the precise determination of blood sirolimus in children with vascular anomalies.

Authors:  Yue-Tao Zhao; Hao-Ran Dai; Yue Li; Yuan-Yuan Zhang; Hong-Li Guo; Xuan-Sheng Ding; Ya-Hui Hu; Feng Chen
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.